Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.
- DOI
- 10.1186/s10020-023-00680-z
- Published
- 2023 Jun 12
- Container
- Molecular medicine (Cambridge, Mass.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10020-023-00680-z,
title = {Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.},
author = {Gong J and Yang R and Zhou M and Chang LJ},
year = {2023},
journal = {Molecular medicine (Cambridge, Mass.)},
doi = {10.1186/s10020-023-00680-z},
url = {https://doi.org/10.1186/s10020-023-00680-z}
}RIS
TY - JOUR TI - Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A. AU - Gong J AU - Yang R AU - Zhou M AU - Chang LJ PY - 2023 JO - Molecular medicine (Cambridge, Mass.) DO - 10.1186/s10020-023-00680-z UR - https://doi.org/10.1186/s10020-023-00680-z ER -
APA
J, G., R, Y., M, Z., & LJ, C. (2023). Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-023-00680-z
Source records
- pubmed · retrieved 2026-09-26T11:30:26.263Z